UltraMIST Cannot Effectively Penetrate a Deep Tissue Injury Bulla
UltraMIST therapy should not be expected to penetrate through an intact bulla overlying a deep tissue injury, as the acoustic impedance mismatch between air and soft tissue results in only 0.1% of the incident ultrasound intensity being delivered into underlying tissue. 1
Physical Limitations of Ultrasound Transmission
The fundamental physics of the UltraMIST (MIST Therapy) system creates a critical barrier to penetration through fluid-filled bullae:
- The device operates at 39.5 kHz low-frequency ultrasound delivered via an atomized saline spray 1
- When measured across the manufacturer-specified treatment range (12.5-20 mm from the transducer), the acoustic intensity ranges from 429-188 mW/cm² 1
- The critical limitation: Due to the acoustic impedance mismatch between air and soft tissue, only 0.1% of incident intensity actually penetrates into the wound site 1
This means that even in optimal conditions without a bulla present, the vast majority of ultrasonic energy is reflected at the air-tissue interface rather than transmitted into deeper tissues.
Implications for Deep Tissue Injury with Bulla
When a bulla is present over a deep tissue injury, you face multiple impedance mismatches:
- Air → bulla fluid interface
- Bulla fluid → bulla membrane interface
- Bulla membrane → underlying damaged tissue interface
Each interface further attenuates the already minimal 0.1% energy transmission, making therapeutic penetration to the deep tissue injury essentially negligible.
Clinical Application Strategy
The bulla should be managed first before considering UltraMIST therapy:
- If the deep tissue injury has an intact bulla, address the bulla according to your facility's wound care protocol (aspiration vs. unroofing vs. leaving intact based on size, location, and infection risk)
- Once the bulla is managed and you have direct access to the wound bed, UltraMIST can be considered as adjunctive therapy
- Timing is critical: Evidence suggests UltraMIST is most effective when initiated within 3-5 days of deep tissue injury onset 2, 3
Evidence for UltraMIST in Deep Tissue Injuries (Without Bullae)
When applied directly to accessible deep tissue injuries, noncontact low-frequency ultrasound shows benefit:
- In a prospective study of 60 subjects with deep tissue pressure injuries, the treatment group (UltraMIST + standard care) showed significantly greater reduction in total surface area (8.8 cm² vs 0.3 cm²) and lower severity scores (7.6 vs 11.9) compared to standard care alone 2
- 50% of treated injuries remained at stage 2 versus 57% progressing to unstageable ulcers in controls 2
- Case series demonstrate that early intervention (within 3-4 days) may prevent progression to higher-stage pressure ulcers 3
Common Pitfall to Avoid
Do not assume that because UltraMIST uses a "mist" delivery system that it can somehow bypass or penetrate through intact skin barriers or bullae. The therapeutic mechanism relies on direct ultrasonic energy transmission to the wound bed, which requires an unobstructed path from the transducer to the target tissue. The saline mist itself does not significantly attenuate the ultrasound 1, but any tissue barrier (including bulla membrane and fluid) will dramatically reduce energy transmission beyond the already minimal 0.1% that crosses the air-tissue interface.